ABOUT THE SPEAKER
Gregory Petsko - Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do.

Why you should listen

Gregory Petsko's own biography, on his Brandeis faculty homepage, might seem intimidatingly abstruse to the non-biochemist -- he studies "the structural basis for efficient enzymic catalysis of proton and hydride transfer; the role of the metal ions in bridged bimetalloenzyme active sites; direct visualization of proteins in action by time-resolved protein crystallography; the evolution of new enzyme activities from old ones; and the biology of the quiescent state in eukaryotic cells."

But for someone so deeply in touch with the minutest parts of our bodies, Petsko is also a wide-ranging mind, concerned about larger health policy issues. The effect of mass population shifts -- such as our current trend toward a senior-citizen society -- maps onto his world of tiny proteins to create a compeling new worldview.

More profile about the speaker
Gregory Petsko | Speaker | TED.com
TED2008

Gregory Petsko: The coming neurological epidemic

Gregory Petsko o nadolazećoj neurološkoj epidemiji

Filmed:
994,855 views

Biokemičar Gregory Petsko predstavlja uvjerljiv argument da ćemo u slijedećih 50 godina vidjeti epidemiju neuroloških bolesti, poput Alzheimerove, kako svjetska populacija stari. Njegovo rješenje: više istraživanja mozga i njegovih funkcija.
- Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do. Full bio

Double-click the English transcript below to play the video.

00:12
UnlessOsim ako we do something to preventspriječiti it,
0
0
2000
Ukoliko ne učinimo nešto da to spriječimo
00:14
over the nextSljedeći 40 yearsgodina we’rere facingokrenut an epidemicepidemija
1
2000
3000
u slijedećih 40 godina, suočit ćemo se sa epidemijom
00:17
of neurologicneurološki diseasesoboljenja on a globalglobalno scaleljestvica.
2
5000
3000
neuroloških bolesti na globalnoj razini.
00:20
A cheeryživahno thought.
3
8000
4000
Vesela pomisao.
00:24
On this mapkarta, everysvaki countryzemlja that’s coloredobojen blueplava
4
12000
3000
Na ovoj mapi, svaka zemlja obojana plavo
00:27
has more than 20 percentposto of its populationpopulacija over the agedob of 65.
5
15000
4000
ima više od 20 posto populacije u dobi od preko 65 godina.
00:31
This is the worldsvijet we liveživjeti in.
6
19000
2000
To je svijet u kojem živimo.
00:33
And this is the worldsvijet your childrendjeca will liveživjeti in.
7
21000
3000
A ovo je svijet u kojem će živjeti naša djeca.
00:37
For 12,000 yearsgodina, the distributiondistribucija of agesdobi in the humanljudski populationpopulacija
8
25000
4000
12.000 godina je distribucija starosti ljudske populacije
00:41
has lookedgledao like a pyramidpiramida, with the oldestnajstariji on topvrh.
9
29000
3000
izgledala poput piramide, sa najstarijima na vrhu.
00:44
It’s alreadyveć flatteningravnanje out.
10
32000
2000
Već sada se izravnava.
00:46
By 2050, it’s going to be a columnkolona and will startpočetak to invertinvertni.
11
34000
4000
A do 2050. će postati stupčasta i počet se izokretat.
00:50
This is why it’s happeningdogađa.
12
38000
3000
Evo zašto se to dešava.
00:53
The averageprosječan lifespanživotni vijek’s more than doubledudvostručio sinceod 1840,
13
41000
3000
Prosječna životna dob se više nego udvostručila od 1840.
00:56
and it’s increasingpovećavajući currentlytrenutno at the ratestopa of about fivepet hourssati everysvaki day.
14
44000
5000
i tenutačno se povećava brzinom od oko pet sati po danu.
01:01
And this is why that’s not entirelypotpuno a good thing:
15
49000
3000
A evo i zašto to nije sasvim dobra stvar:
01:04
because over the agedob of 65, your riskrizik of gettinguzimajući AlzheimerAlzheimerova’s
16
52000
4000
zbog toga što će pri dobi većoj od 65 g., rizik da dobijete Alzheimerovu
01:08
or ParkinsonParkinsonova’s diseasebolest will increasepovećati exponentiallyeksponencijalno.
17
56000
4000
ili Parkinsonovu bolest rasti eksponencijalno.
01:12
By 2050, there’llll be about 32 millionmilijuna people in the UnitedUjedinjeni StatesDržava
18
60000
4000
2050. će u Sjedinjenim Državama biti oko 32 milijuna ljudi
01:16
over the agedob of 80, and unlessosim ako we do something about it,
19
64000
3000
starijih od 80 g. i ukoliko ne poduzmemo nešto,
01:19
halfpola of them will have AlzheimerAlzheimerova’s diseasebolest
20
67000
2000
pola od njih će imati Alzheimerovu bolest,
01:21
and threetri millionmilijuna more will have ParkinsonParkinsonova’s diseasebolest.
21
69000
3000
a još tri milijuna će imati Parkinsonovu bolest.
01:24
Right now, those and other neurologicneurološki diseasesoboljenja --
22
72000
3000
Upravo sada, te i druge neurološke bolesti --
01:27
for whichkoji we have no curelijek or preventionprevencija --
23
75000
3000
za koje nemamo lijek ili prevenciju --
01:30
costcijena about a thirdtreći of a trillionbilijuna dollarsdolara a yeargodina.
24
78000
2000
koštaju oko trećinu bilijuna dolara svake godine.
01:32
It will be well over a trillionbilijuna dollarsdolara by 2050.
25
80000
4000
To će iznositi dobrano više od bilijun dolara do 2050.
01:36
AlzheimerAlzheimerova’s diseasebolest startspočinje when a proteinprotein
26
84000
2000
Alzheimerova bolest započinje kada se protein
01:38
that should be foldedpresavijen up properlypropisno
27
86000
2000
koji bi se trebao pravilno foldati (op. poprimiti strukturu)
01:40
misfoldsmisfolds into a kindljubazan of dementedlud origamiOrigami.
28
88000
4000
misfolda u dementan origami.
01:44
So one approachpristup we’rere takinguzimanje is to try to designdizajn drugslijekovi
29
92000
3000
Dakle jedan pristup koji poduzimamo je da pokušavamo dizajnirati lijekove
01:47
that functionfunkcija like molecularmolekularna ScotchViski tapetraka,
30
95000
3000
koji će funkcionirati poput molekulske ljepljive vrpce,
01:50
to holddržati the proteinprotein into its properodgovarajuće shapeoblik.
31
98000
3000
kako bi se protein zadržao u svom ispravnom obliku.
01:53
That would keep it from formingformiranje the tanglespoteškoća
32
101000
2000
To bi ga spriječilo da se zamrsi,
01:55
that seemčiniti se to killubiti largeveliki sectionsdijelovi of the brainmozak when they do.
33
103000
4000
što izgleda, ubija velike dijelove mozga, kada se desi.
01:59
InterestinglyZanimljivo enoughdovoljno, other neurologicneurološki diseasesoboljenja
34
107000
2000
Podjednako zanimljivo je da, druge neurološke bolesti,
02:01
whichkoji affectutjecati very differentdrugačiji partsdijelovi of the brainmozak
35
109000
3000
koje utječu na vrlo različite dijelove mozga,
02:04
alsotakođer showpokazati tanglespoteškoća of misfoldedmisfolded proteinprotein,
36
112000
3000
također pokazuju klupka misfoldanih proteina,
02:07
whichkoji suggestssugerira that the approachpristup mightmoć be a generalgeneral one,
37
115000
3000
što upućuje na to da bi pristup mogao biti općenit
02:10
and mightmoć be used to curelijek manymnogi neurologicneurološki diseasesoboljenja,
38
118000
2000
i iskoristiv za liječenje mnogih neuroloških bolesti,
02:12
not just AlzheimerAlzheimerova’s diseasebolest.
39
120000
2000
ne samo Alzheimerove bolesti.
02:14
There’s alsotakođer a fascinatingfascinantan connectionveza to cancerRak here,
40
122000
3000
Ovdje je prisutna i fascinantna povezanost sa rakom,
02:17
because people with neurologicneurološki diseasesoboljenja
41
125000
2000
jer ljudi s neurološkim oboljenjem
02:19
have a very lownizak incidenceučestalost of mostnajviše cancersraka.
42
127000
3000
imaju vrlo malu učestalost većine rakova.
02:22
And this is a connectionveza that mostnajviše people arenNećete moći’t pursuingslijedeći right now,
43
130000
3000
A to je poveznica s kojom se većina ljudi trenutačno ne bavi,
02:25
but whichkoji we’rere fascinatedopčinjen by.
44
133000
3000
ali kojom smo fascinirani.
02:28
MostVećina of the importantvažno and all of the creativekreativan work in this areapodručje
45
136000
3000
Većina značajnog i sav kreativan rad u tom području
02:31
is beingbiće fundedfinansiran by privateprivatna philanthropiesphilanthropies.
46
139000
3000
financiran je od strane privatnih filantropa.
02:34
And there’s tremendousogroman scopedjelokrug for additionalDodatne privateprivatna help here,
47
142000
3000
Prostor za dodatnu privatnu pomoć je ogroman,
02:37
because the governmentvlada has droppedpao the balllopta on much of this, I’m afraiduplašen.
48
145000
3000
jer bojim se da je vlada odustala
02:40
In the meantimeu međuvremenu, while we’rere waitingčekanje for all these things to happendogoditi se,
49
148000
4000
U međuvremenu, dok čekamo da se sve te stvari dese,
02:44
here’s what you can do for yourselfsami.
50
152000
2000
evo što možete učiniti za sebe.
02:46
If you want to lowerdonji your riskrizik of ParkinsonParkinsonova’s diseasebolest,
51
154000
2000
Ako želite smanjiti svoj rizik od Parkinsonove bolesti,
02:48
caffeinekofein is protectivezaštitni to some extentopseg; nobodynitko knowszna why.
52
156000
5000
kofein djeluje donekle zaštitno; nitko ne zna zašto.
02:53
HeadGlava injuriesozljede are badloše for you. They leaddovesti to ParkinsonParkinsonova’s diseasebolest.
53
161000
3000
Ozlijede glave su loše za vas. One dovode do Parkinsonove bolesti.
02:56
And the AvianPtičje FluGripe is alsotakođer not a good ideaideja.
54
164000
4000
A ptičja gripa također nije dobra ideja.
03:01
As fardaleko as protectingzaštitu yourselfsami againstprotiv AlzheimerAlzheimerova’s diseasebolest,
55
169000
3000
Što se tiče zaštite od Alzheimerove bolesti,
03:04
well, it turnsokreti out that fishriba oilulje has the effectposljedica
56
172000
3000
ispada da riblje ulje
03:07
of reducingsmanjivanje your riskrizik for AlzheimerAlzheimerova’s diseasebolest.
57
175000
3000
smanjuje rizik od oboljenja.
03:10
You should alsotakođer keep your bloodkrv pressurepritisak down,
58
178000
2000
Trebali bi također držati krvni tlak pod kontrolom,
03:12
because chronickronični highvisok bloodkrv pressurepritisak
59
180000
2000
jer je kronični visoki krvni tlak
03:14
is the biggestnajveći singlesingl riskrizik factorfaktor for AlzheimerAlzheimerova’s diseasebolest.
60
182000
2000
najveći pojedinačni rizični faktor za Alzheimerovu bolest.
03:16
It’s alsotakođer the biggestnajveći riskrizik factorfaktor for glaucomaglaukom,
61
184000
3000
Također je i najveći rizični faktor za glaukom,
03:19
whichkoji is just AlzheimerAlzheimerova’s diseasebolest of the eyeoko.
62
187000
3000
koji je Alzheimerova bolest očiju.
03:22
And of coursenaravno, when it comesdolazi to cognitivespoznajni effectsefekti,
63
190000
2000
I naravno, kada se radi o kognitivnim sposobnostima,
03:24
"use it or loseizgubiti it" appliesvrijedi,
64
192000
2000
primjenjiva je izreka "use it or lose it" ("koristi ili izgubi")
03:26
so you want to stayboravak mentallymentalno stimulatedstimulirana.
65
194000
2000
tako da želite ostati mentalno stimulirani.
03:28
But hey, you’rere listeningslušanje to me.
66
196000
2000
Ali, već ionako slušate mene.
03:30
So you’veve got that coveredpokriven.
67
198000
2000
Tako da je to rješeno.
03:32
And one finalkonačni thing. WishŽelja people like me lucksreća, okay?
68
200000
4000
I jedna posljednja stvar. Poželite ljudima poput mene sreću, u redu?
03:36
Because the clocksat is tickingotkucavanje for all of us.
69
204000
2000
Jer sat nam svima otkucava.
03:38
Thank you.
70
206000
3000
Hvala vam.
Translated by Zeljko Babic
Reviewed by Zrinka Gattin

▲Back to top

ABOUT THE SPEAKER
Gregory Petsko - Bioengineer
Gregory Petsko is a biochemist who studies the proteins of the body and their biochemical function. Working with Dagmar Ringe, he's doing pioneering work in the way we look at proteins and what they do.

Why you should listen

Gregory Petsko's own biography, on his Brandeis faculty homepage, might seem intimidatingly abstruse to the non-biochemist -- he studies "the structural basis for efficient enzymic catalysis of proton and hydride transfer; the role of the metal ions in bridged bimetalloenzyme active sites; direct visualization of proteins in action by time-resolved protein crystallography; the evolution of new enzyme activities from old ones; and the biology of the quiescent state in eukaryotic cells."

But for someone so deeply in touch with the minutest parts of our bodies, Petsko is also a wide-ranging mind, concerned about larger health policy issues. The effect of mass population shifts -- such as our current trend toward a senior-citizen society -- maps onto his world of tiny proteins to create a compeling new worldview.

More profile about the speaker
Gregory Petsko | Speaker | TED.com